Today human mankind stands in the middle of deep scientific understanding of United Nations and Global Sustainable Development Goals. In the similar vision, medical science and health science perspectives are in the middle of scientific rejuvenation and scientific steadfastness. Schizophrenia is an extremely difficult ailment to treat. The author is suffering from schizophrenia since November,1993. He is diagnosed with glaucoma in his right eye since October, 2012. Today he is beset and replete with different symptoms of schizophrenia. Long years of illness has passed since 1993. Science and technology today has no answers towards the cure and treatment of schizophrenia. The author in this article elucidates with cogent and lucid insight his medical diagnosis of the treatment of schizophrenia and the immense trials and tribulations in his life. With immense agony and pain, the author depicts profoundly the needs of psychological and psychiatric help in the treatment and cure of schizophrenia.

Infectious mononucleosis (IM) or Mononucleosis syndrome is caused by an acute infection of Epstein-Barr virus (EBV). This study was aimed at determining the levels of haemoglobin, total white blood cell (TWBC) count, neutrophils, lymphocytes, monocytes and eosinophils in patients infected with infectious mononucleosis at Federal Teaching Hospital, Owerri. A total of sixty subjects (30 patients and 30 controls) were enrolled in the study after giving their informed consent and completing questionnaires. The procedure was carried out at Federal Teaching Hospital, Owerri. Five millilitres of venous blood sample was collected at the ante-cubital vein aseptically and was dispensed into ethylenediaminetetraacetic acid (EDTA) containers. The EDTA containers were properly labeled with the subject’s name, sample number and date of collection. Haemoglobin was determined using the cyanmethaemoglobin method, TWBC was determined using the improved Neubauer counting chamber, while the differential count was determined using Romanowsky staining method. Data generated were analyzed using SPSS version 27, and mean, standard deviation, t-test, correlation and p-value were determined. The mean values of haemoglobin (8.9±1.44)g/dl and neutrophils (28.53±12.77)%, were significantly reduced in patients with infectious mononucleosis when compared to the controls (12.83±1.34)g/dl and (54.27±10.20 ((p=0.000 and p=0.001)) The mean values of TWBC (17.66±8.54)%, lymphocytes (59.87±13.14)% and monocytes (10.30±6.68)%)% were significantly increased in patients with infectious mononucleosis when compared to the controls (6.17±2.53)%, (49.23±13.57)% and (5.93±2.91)% ) respectively (p=0.000, p=0.003 and p=0.002). There was no significant difference in the mean value of eosinophil count in infectious mononucleosis (1.30±1.56)% (p=0.784) when compared to the controls (1.20±1.24)%. There were no significant differences in the mean values of haemoglobin, TWBC, neutrophil, lymphocyte, monocyte and eosinophil counts in male patients with infectious mononucleosis (9.14±1.52)g/dl, (19.16±9.36)x109/L, (27.69±11.18)%, (59.44±11.17), (10.13±6.12)% and (1.44±1.89)% when compared to the female patients (8.82±1.38)g/dl, (15.94±7.46)x109/L, (29.50±14.38)%, (60.36±15.51)%, (10.50±7.50)% and (1.14±1.09)% (p=0.568, p=0.311, p=0.705, p=0.852, p=0.881 and p=0.614). There was a non-significant positive correlation of haemoglobin with TWBC, neutrophils, lymphocytes, monocytes and eosinophils in infectious mononucleosis patients (r=0.17, p=0.357; r=0.15, p=0.421, r=0.07, p=0.730, r=0.11, p=0.563 and r=0.06, p=0.751). In conclusion, the data in the present study showed that infectious mononucleosis is characterized by increase in lymphocytes and monocytes with decreased levels of haemoglobin and neutrophils. Haemoglobin concentration does not have any relationship with white blood cells in patients with infectious mononucleosis. In the management and treatment of patients with infectious mononucleosis, complete blood count should be incorporated as a routine test, so as to aid in the diagnosis.

Background: Syringomyelia (Syr) is a rare, progressive neurological disorder characterized by the formation of a fluid-filled cavity (syrinx) within the spinal cord, leading to sensory and motor dysfunction. It is challenging to cure, and available treatments often have limited effectiveness. Recurrence is commonly observed after treatment. Objective: This study explores the role of Guan Yin Citta Dharma Door in managing Syr, presenting 2 cases in which Dharma practice led to significant symptom relief. Methods: This study examines two cases of patients diagnosed with Syr who adopted Buddhist practices based on the teachings of Dharma Master Jun Hong Lu. The first patient practiced making vows, reciting Buddhist scriptures, and liberating lives, with progress assessed through symptom relief and overall well-being. In the second case, the patient incorporated Dharma practices to aid recovery following surgery. Results: Through dedicated Dharma practice, the patient in Case 1 experienced significant symptom improvement, reduced pain, and survival beyond the medically expected prognosis. Similarly, in Case 2, Buddhist practices not only supported post-surgical recovery but also alleviated persistent pain and emotional suffering, leading to a profound transformation. These cases underscore the potential benefits of spiritual healing in managing Syr. Conclusion: This study suggests that Guan Yin Citta Dharma Door may provide an alternative approach to improving the quality of life in patients with Syr. While further research is needed, the integration of Dharma practices with conventional treatments may offer a more holistic strategy for managing neurological diseases.